Insider · CIK 0001145914
Joseph K Schachle
cooofficer
Files at IRD (Opus Genetics, Inc.). First filing Mar 18, 2026, latest Mar 18, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $20k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IRD: Opus Genetics, Inc.
IRDOct 9, 2026 · close 4.65
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Opus Genetics, Inc. | $20k 3,719 shares | -1% | +631% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | IRD Opus Genetics, Inc. | SOpen-market sale Common Stock | -3,719 | $5.25 | $20k | 300,781 | Mar 18, 2026 |
| Jan 22, 2026 | IRD Opus Genetics, Inc. | AGrant or award Common Stock | +250,000 | $0.00 | $0 | 304,500 | Jan 26, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.